All News #Library
Biotech
Nasus Advances NS002 to Pivotal Study After Positive Phase 2
25 Mar 2026 //
GLOBENEWSWIRE
Nasus Pharma Announces Top Line Data from Phase 2 Study of NS002
16 Mar 2026 //
GLOBENEWSWIRE
Nasus Pharma Unveils Topline Data from NS002 Phase 2 Trial
09 Mar 2026 //
GLOBENEWSWIRE
Nasus Pharma Reports Positive Phase 2 Results For NS002 Powder
20 Jan 2026 //
GLOBENEWSWIRE
Nasus Pharma Reports Positive Phase 2 Results For NS002
20 Jan 2026 //
GLOBENEWSWIRE
Nasus Pharma Doses First Patient in Phase 2 NS002 Trial
18 Nov 2025 //
GLOBENEWSWIRE
Nasus Pharma Receives Health Canada Approval For NS002
06 Nov 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support